Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1992 Jun;36(6):1322–1324. doi: 10.1128/aac.36.6.1322

Antimycoplasmal activities of new quinolones, tetracyclines, and macrolides against Mycoplasma pneumoniae.

S Arai 1, Y Gohara 1, K Kuwano 1, T Kawashima 1
PMCID: PMC190339  PMID: 1416832

Abstract

Fifty strains of Mycoplasma pneumoniae were tested for susceptibility to new quinolones, tetracyclines, and macrolides. Temafloxacin, ofloxacin, and ciprofloxacin possessed the most mycoplasmacidal activity against these organisms. The MBC for 50% of the strains (MBC50)-to-MIC50 ratio for each of these drugs was 4. The MBC50-to-MIC50 ratios for the tetracyclines and macrolides were markedly higher, within a range of 32 to 2,000. On the basis of these results, temafloxacin and ofloxacin might be promising antimicrobial agents for the treatment of mycoplasmal infection.

Full text

PDF
1322

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cassell G. H., Waites K. B., Pate M. S., Canupp K. C., Duffy L. B. Comparative susceptibility of Mycoplasma pneumoniae to erythromycin, ciprofloxacin, and lomefloxacin. Diagn Microbiol Infect Dis. 1989 Sep-Oct;12(5):433–435. doi: 10.1016/0732-8893(89)90115-6. [DOI] [PubMed] [Google Scholar]
  2. HUNTER T. H. Speculations on the mechanism of cure of bacterial endocarditis. J Am Med Assoc. 1950 Oct 14;144(7):524–527. doi: 10.1001/jama.1950.02920070012004. [DOI] [PubMed] [Google Scholar]
  3. Heifets L., Lindholm-Levy P. Comparison of bactericidal activities of streptomycin, amikacin, kanamycin, and capreomycin against Mycobacterium avium and M. tuberculosis. Antimicrob Agents Chemother. 1989 Aug;33(8):1298–1301. doi: 10.1128/aac.33.8.1298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Misu T., Arai S., Furukawa M., Yamamoto Y., Miyazaki T. Effects of rokitamycin and other macrolide antibiotics on Mycoplasma pneumoniae in L cells. Antimicrob Agents Chemother. 1987 Nov;31(11):1843–1845. doi: 10.1128/aac.31.11.1843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Niitu Y., Hasegawa S., Suetake T., Kubota H., Komatsu S., Horikawa M. Resistance of Mycoplasma pneumoniae to erythromycin and other antibiotics. J Pediatr. 1970 Mar;76(3):438–443. doi: 10.1016/s0022-3476(70)80485-1. [DOI] [PubMed] [Google Scholar]
  6. Nitu Y., Hasegawa S., Kubota H. In vitro development of resistance to erythromycin, other macrolide antibiotics, and lincomycin in Mycoplasma pneumoniae. Antimicrob Agents Chemother. 1974 May;5(5):513–519. doi: 10.1128/aac.5.5.513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Osada Y., Ogawa H. Antimycoplasmal activity of ofloxacin (DL-8280). Antimicrob Agents Chemother. 1983 Mar;23(3):509–511. doi: 10.1128/aac.23.3.509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Pearson R. D., Steigbigel R. T., Davis H. T., Chapman S. W. Method of reliable determination of minimal lethal antibiotic concentrations. Antimicrob Agents Chemother. 1980 Nov;18(5):699–708. doi: 10.1128/aac.18.5.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Rasch J. R., Mogabgab W. J. Therapeutic effect of erythromycin on Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother (Bethesda) 1965;5:693–699. [PubMed] [Google Scholar]
  10. Scheld W. M., Sande M. A. Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits. J Clin Invest. 1983 Mar;71(3):411–419. doi: 10.1172/JCI110785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Stratton C. W. The role of the microbiology laboratory in the treatment of infective endocarditis. J Antimicrob Chemother. 1987 Sep;20 (Suppl A):41–49. doi: 10.1093/jac/20.suppl_a.41. [DOI] [PubMed] [Google Scholar]
  12. Taylor P. C., Schoenknecht F. D., Sherris J. C., Linner E. C. Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factors. Antimicrob Agents Chemother. 1983 Jan;23(1):142–150. doi: 10.1128/aac.23.1.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Tuomanen E. Phenotypic tolerance: the search for beta-lactam antibiotics that kill nongrowing bacteria. Rev Infect Dis. 1986 Jul-Aug;8 (Suppl 3):S279–S291. doi: 10.1093/clinids/8.supplement_3.s279. [DOI] [PubMed] [Google Scholar]
  14. Waites K. B., Cassell G. H., Canupp K. C., Fernandes P. B. In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones. Antimicrob Agents Chemother. 1988 Oct;32(10):1500–1502. doi: 10.1128/aac.32.10.1500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wenzel R. P., Hendley J. O., Dodd W. K., Gwaltney J. M. Comparison of josamycin and erythromycin in the therapy of Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother. 1976 Dec;10(6):899–901. doi: 10.1128/aac.10.6.899. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES